Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview

Precision Biosciences

03/08/2026 14:56

Precision BioSciences Inc DTIL.OQ DTIL.O is expected to  show a rise in quarterly revenue when it reports  results on August 6 for the period ending June 30 2026
The Durham North Carolina-based  company is expected to report a 6,150.0% increase in revenue to $1.125 million from $18 thousand a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Precision BioSciences Inc is for a loss of 79 cents per share. 
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Precision BioSciences Inc is $20.00, about 186.1% above its last closing price of $6.99
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.61
-0.65
-0.75
Missed
-14.5
Dec. 31 2026
-0.62
-0.53
1.05
Beat
296.3
Sep. 30 2025
-1.94
-1.34
-1.84
Missed
-37.3​
Jun. 30 2025
-1.65
-1.57
-2.13
Missed
-36
​​Mar. 31 2025
-1.86
-1.72
-2.21
Missed
-28.7
Dec. 31 2024
-1.96
-2.22
Missed
-13.1​
Sep. 30 2024
-2.23
-1.92
-2.25
Missed
-17
Jun. 30 2024
-1.68
-1.50
4.67
Beat
410.3
This summary was machine generated August 3 at 13:56 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)